PROQR THERAPEUTICS NV (PRQR:NASDAQ)
$1.7 -0.03 (-1.7341%)
Analysed PROQR THERAPEUTICS NV (PRQR:NASDAQ) News Sources
ProQR Announces Annual General Meeting of Shareholders to be Held June 2, 2026
04-05-2026
yahoo.com
3 Promising Penny Stocks With Market Caps Up To $600M
06-05-2026
yahoo.com
Earnings Preview: ProQR (PRQR) Q1 Earnings Expected to Decline
07-05-2026
yahoo.com
ProQR Announces Multiple Upcoming Scientific Conference Presentations Highlighting the Breadth of its Axiomer™ RNA Editing Platform
11-05-2026
yahoo.com
ProQR Announces First Quarter 2026 Operating and Financial Results
12-05-2026
yahoo.com
Kamada (KMDA) Misses Q1 Earnings and Revenue Estimates
13-05-2026
yahoo.com
ProQR Therapeutics N.V. (NASDAQ:PRQR) Analysts Just Slashed This Year's Revenue Estimates By 22%
14-05-2026
yahoo.com
Undervalued Penny Stocks To Consider In June 2026
08-06-2026
yahoo.com
ProQR Announces Positive Phase 1 Target Engagement Data for AX-0810, Establishing First Clinical Validation of the Axiomer RNA Editing Platform
25-06-2026
yahoo.com
ProQR Prices $50.0 Million Underwritten Registered Direct Offering and Concurrent Private Placement
25-06-2026
yahoo.com
What is the current price of PROQR THERAPEUTICS NV (PRQR:NASDAQ)?
The current price of PROQR THERAPEUTICS NV (PRQR:NASDAQ) is $1.7.
PROQR THERAPEUTICS NV (PRQR:NASDAQ) absolute price change since previous trading day?
The absolute price change of PROQR THERAPEUTICS NV (PRQR:NASDAQ) since the previous trading day is $-0.03.
PROQR THERAPEUTICS NV (PRQR:NASDAQ) percentage price change since previous trading day?
The percentage price change of PROQR THERAPEUTICS NV (PRQR:NASDAQ) since the previous trading day is -1.7341%.
What is the most recent average sentiment score for PROQR THERAPEUTICS NV (PRQR:NASDAQ)?
The most recent average sentiment score for PROQR THERAPEUTICS NV (PRQR:NASDAQ) is 46 out of 100.
What is the most recent average sentiment for PROQR THERAPEUTICS NV (PRQR:NASDAQ)?
The most recent sentiment for PROQR THERAPEUTICS NV (PRQR:NASDAQ) is .
SEC-8K** Filing Available For PROQR THERAPEUTICS NV (PRQR:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.